Eli Lilly chases $100bn weight loss market with $5.3bn US investment
US drugmaker races to scale up ingredient production to meet demand for Mounjaro and Zepbound jabs
Full Article
Eli Lilly chases $100bn weight loss market with $5.3bn US investment
FT.com
0 shares
1 views
You might like
Related news coverage
New Analysis Suggests Long-Term Effectiveness for Wegovy Users
New Analysis Suggests , Long-Term Effectiveness , for Wegovy Users .
NBC reports that patients taking
Novo Nordisk's..
Wibbitz Top Stories